Clinical Trial

Total Intravenous Anesthesia and Recurrence Free Survival

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators propose to compare recurrence-free survival in patients having potentially curative (Stages 1-3) surgery for esophageal cancer who will be randomly assigned to propofol-based total intravenous anesthesia or sevoflurane-based balanced general anesthesia.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-08-12; most recent amendment 2024-12-03.
Status change: Not Yet Recruiting → Recruiting 2020-08-26
Trial Details
NCT Number NCT04513808
Lead Sponsor The Cleveland Clinic
Conditions Esophageal Cancer
Enrollment 1,614 participants
Start Date 2020-08-15
Primary Completion 2025-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-04